Filter
504
Filtered Results: 504
Text search:
T.
Colton
Featured
Recommendations
37
New Publications
96
Language
Document type
No document type
256
Studies & Reports
107
Guidelines
82
Manuals
28
Strategic & Response Plan
12
Fact sheets
8
Training Material
7
Situation Updates
2
Brochures
1
Resource Platforms
1
Countries / Regions
India
29
Global
21
Congo, Democratic Republic of
13
South Africa
13
Senegal
11
Latin America and the Carribbean
10
Central African Republic
9
Kenya
8
Cameroon
8
Burkina Faso
8
Zambia
8
Colombia
7
Nigeria
7
Ghana
6
Paraguay
6
Ethiopia
6
Myanmar / Burma
6
Sierra Leone
5
Rwanda
5
Peru
5
Guinea
5
Argentina
5
Benin
4
Venezuela
4
Tanzania
4
Western and Central Europe
4
Bolivia
4
Namibia
4
Philippines
3
Haiti
3
Uganda
3
Papua New Guinea
3
Brazil
3
Mali
3
Indonesia
3
Liberia
3
Madagascar
3
Nepal
2
El Salvador
2
Togo
2
Mozambique
2
Africa
2
Cambodia
2
Asia
2
East and Southern Africa
2
Bangladesh
2
Eastern Europe
2
Russia
2
Ecuador
2
Guatemala
2
Timor Leste/ East Timor
1
Chile
1
Malawi
1
Germany
1
West and Central Africa
1
South–East Asia Region
1
North America
1
Jamaica
1
Côte d’Ivoire / Ivory Coast
1
Vietnam
1
Honduras
1
Chad
1
Libya
1
Botswana
1
Eswatini/ Swaziland
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
202
Clinical Guidelines
49
Public Health
24
Capacity Building
19
Key Resources
14
Pharmacy & Technologies
8
Women & Child Health
6
Toolboxes
TB
47
NTDs
44
Planetary Health
31
Mental Health
30
HIV
22
COVID-19
18
Pharmacy
17
Disability
15
Ebola & Marburg
15
AMR
14
Caregiver
11
Rapid Response
10
Social Ethics
8
NCDs
8
Global Health Education
8
Refugee
5
Health Financing Toolbox
5
Conflict
5
Cholera
4
Specific Hazards
3
Natural Hazards
1
Zika
1
Polio
1
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these...
The objective of the study was the validation and implementation of GeneXpert MTB/RIF for routine use in the rapid detection of tuberculosis and sensitivity to rifampicin in clinical samples; for this, 1592 respiratory samples were collected and analyzed in the laboratory of Instituto Nacional de In...
Guidelines for the diagnosis and treatment of COVID-19 in intensive care units
Mental health issues are usually given very low priority in health service policies. Although this is changing, African countries are still confronted with so many problems caused by communicable diseases and malnutrition that they have not woken up to the impact of mental disorders. Every country m...
The current document is anupdate of the guidelines developed by the EUCAST subcommittee on detection of resistance mechanisms. The EUCAST Steering Committee has carried out the current update. The document has been developed mainly for routine use in clinical laboratories and doesnot cover technical...
BMJ Global Health2020;5:e001980. doi:10.1136/bmjgh-2019-00198
(updated December 2014).
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these...
Partout dans le monde, les sociétés ont produit, adapté et fait évoluer leur habitat pour répondre au mieux à leurs besoins et
aspirations, et ce en faisant le meilleur usage des ressources naturelles disponibles localement et en développant leurs propres
capacités. Les stratégies qui e...
National action plans on antimicrobial resistance (AMR) often overlook the critical intersection of gender, despite evidence that exposure and susceptibility to infection, health-seeking behaviours, as well as antimicrobial prescribing and use patterns are all influenced by gender.
Examination of the business behavior of Boehringer Ingelheim, Bayer and Baxter in India
